Article
Exendin-4 attenuates atherosclerosis progression via controlling hematopoietic stem/progenitor cell proliferation
1 Feb 2023
Abstract excerpt
Beyond glycemic control, applications of glucagon-like peptide-1 receptor (GLP-1r) agonists (GLP-1 RAs) inhibit inflammation and plaque development in murine atherosclerotic models. However, whether they modulate hematopoietic stem/progenitor cells (HSPCs) to prohibit skewed myelopoiesis in hypercholesteremia remains unknown. In this study, GLP-1r expression in fluorescence-activated cell sorting (FACS)-sorted...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
